{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:30:09Z","timestamp":1790501409414,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0137","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"349-364","source":"Crossref","is-referenced-by-count":34,"title":["Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function"],"prefix":"10.1053","volume":"14","author":[{"given":"Dominique","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Ribba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Maurice","family":"Lavergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Mazurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0137_RF1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(76)90729-7","article-title":"Persistent gastrointestinal bleeding due to angiodysplasia of the gut in von Willebrand's disease","volume":"2","author":"Ramsay","year":"1976","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0137_RF3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0038-1649623","article-title":"International survey of patients with von Willebrand disease and angiodysplasia","volume":"70","author":"Fressinaud","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand's disease or factor XI deficiency","volume":"105","author":"Kadir","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beha.2001.0137_RF5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V69.3.786.786","article-title":"Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease","volume":"69","author":"Rick","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1365-2516.1998.440654.x","article-title":"Diagnosis of von Willebrand disease","volume":"4","author":"Federici","year":"1998","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0137_RF8","doi-asserted-by":"crossref","DOI":"10.1007\/s005990050046","article-title":"Laboratory diagnosis of von Willebrand disease","volume":"28","author":"Veyradier","year":"1998","journal-title":"International Journal of Clinical Laboratory Research"},{"key":"10.1053\/beha.2001.0137_RF9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","article-title":"von Willebrand factor. A reduced and alkylated 52\/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib","volume":"261","author":"Fujimura","year":"1986","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF10","doi-asserted-by":"crossref","first-page":"18172","DOI":"10.1016\/S0021-9258(18)55251-0","article-title":"Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin\u2014a model for the regulation of von Willebrand factor binding to platelet glycoprotein-Ib","volume":"266","author":"Sugimoto","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF11","doi-asserted-by":"crossref","DOI":"10.1021\/bi00374a004","article-title":"Localization of binding sites within human von Willebrand factor for monomeric type III collagen","volume":"25","author":"Roth","year":"1986","journal-title":"Biochemistry"},{"key":"10.1053\/beha.2001.0137_RF12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood.V70.5.1577.1577","article-title":"Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly911 and Glu1365","volume":"70","author":"Kalafatis","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF13","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/S0021-9258(19)50746-3","article-title":"Selective inactivation of the Arg\u2013Gly\u2013Asp\u2013Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis","volume":"267","author":"Beacham","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF14","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V86.3.1035.1035","article-title":"Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor","volume":"86","author":"Lankhof","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0037-1615051","article-title":"Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease","volume":"79","author":"Holmberg","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF16","first-page":"15","article-title":"Phenotype IIC von Willebrand disease: the expression of three mutant recombinant von Willebrand factors (VWF) confirms the importance of the D2 domain of VWF propeptide in the multimer assembly process","volume":"93","author":"Gaucher","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0609.1998.tb01076.x","article-title":"A new candidate mutation (N528S) within the von Willebrand factor propeptide identified in a Japanese patient with phenotype IIC of von Willebrand disease","volume":"61","author":"Gaucher","year":"1998","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00209487","article-title":"Identification of a candidate missense mutation in a family of von Willebrand disease type IIC","volume":"95","author":"Schneppenheim","year":"1995","journal-title":"Human Genetics"},{"key":"10.1053\/beha.2001.0137_RF19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"84","author":"Gaucher","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF20","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1002\/j.1460-2075.1987.tb02591.x","article-title":"Expression of variant von Willebrand factor (VWF) cDNA in heterologous cells: requirement of the pro-polypeptide in VWF multimer formation","volume":"6","author":"Verweij","year":"1987","journal-title":"EMBO Journal"},{"key":"10.1053\/beha.2001.0137_RF21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(88)90511-9","article-title":"The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers","volume":"52","author":"Wise","year":"1988","journal-title":"Cell"},{"key":"10.1053\/beha.2001.0137_RF22","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1016\/S0021-9258(18)80024-2","article-title":"In vitro multimerization of von Willebrand factor is triggered by low pH","volume":"264","author":"Mayadas","year":"1989","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF23","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1073\/pnas.89.8.3531","article-title":"Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly","volume":"89","author":"Mayadas","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0137_RF24","first-page":"136","article-title":"von Willebrand disease type 2M \u2018Vicenza\u2019 in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families","volume":"82","author":"Schneppenheim","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"von Willebrand disease \u2018Vicenza\u2019 with larger-than-normal (supranormal) von Willebrand factor multimers","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0049-3848(97)00104-7","article-title":"New families with von Willebrand disease type 2M (Vicenza)","volume":"87","author":"Zieger","year":"1997","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0137_RF27","first-page":"82","article-title":"\u2018Vicenza\u2019 variant von Willebrand disease (ultralarge VWF multimers): laboratory features and prevalence","volume":"30","author":"Svirin","year":"2000","journal-title":"Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF28","first-page":"283","article-title":"Cysteine mutations of von Willebrand factor correlate with different types of von Willebrand disease","volume":"82","author":"Schneppenheim","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199701000-00001","article-title":"von Willebrand disease","volume":"76","author":"Nichols","year":"1997","journal-title":"Medicine"},{"key":"10.1053\/beha.2001.0137_RF30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"Holmberg","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0137_RF31","doi-asserted-by":"crossref","first-page":"20497","DOI":"10.1016\/S0021-9258(20)80753-4","article-title":"Type-IIB mutation His-505\u2192Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein-Ib","volume":"268","author":"Rabinowitz","year":"1993","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-0038-1650599","article-title":"Characterization of recombinant von Willebrand factors mutated on cysteine 509 or 695","volume":"76","author":"Siguret","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2141.1992.tb04595.x","article-title":"Defects in type-IIA von Willebrand disease\u2014a cysteine-509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein-Ib-IX","volume":"82","author":"Lavergne","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF34","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V78.7.1738.1738","article-title":"Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type-IIB von Willebrand disease","volume":"78","author":"Ribba","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1365-2141.1998.01040.x","article-title":"Identification of new type 2B von Willebrand disease mutations: Arg543Gln, Arg545Pro and Arg578Leu","volume":"103","author":"Hilbert","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2141.1999.01358.x","article-title":"Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease","volume":"105","author":"Facey","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF37","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI115122","article-title":"Molecular basis of von Willebrand disease type-IIB\u2014candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein-Ib binding sequences","volume":"87","author":"Randi","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0137_RF38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0609.1991.tb01858.x","article-title":"An Arg545\u2192Cys545 substitution mutation of the von Willebrand factor in type-IIB von Willebrand's disease","volume":"47","author":"Donner","year":"1991","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1055\/s-0038-1657699","article-title":"A type 2B von Willebrand disease mutation (Ile(546)\u2192Val) associated with an unusual phenotype","volume":"78","author":"Federici","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2141.1995.tb08922.x","article-title":"Rapid genotype analysis in type 2B von Willebrand's disease using a universal heteroduplex generator","volume":"89","author":"Wood","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF41","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1073\/pnas.88.7.2946","article-title":"Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor","volume":"88","author":"Ware","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0137_RF42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood.V83.3.833.833","article-title":"Discrepancy between IIA-phenotype and IIB-genotype in a patient with a variant of von Willebrand disease","volume":"83","author":"Ribba","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF43","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V87.6.2322.bloodjournal8762322","article-title":"Comparative analysis of type 2B von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets","volume":"87","author":"Cooney","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI115123","article-title":"The molecular defect in type-IIB von Willebrand disease\u2014identification of four potential missense mutations within the putative GpIb binding domain","volume":"87","author":"Cooney","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0137_RF45","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood.V79.8.2048.2048","article-title":"Expressed full-length von Willebrand factor containing missense mutations linked to type-IIB von Willebrand disease shows enhanced binding to platelets","volume":"79","author":"Kroner","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF46","doi-asserted-by":"crossref","first-page":"21187","DOI":"10.1016\/S0021-9258(19)36815-2","article-title":"Recombinant von Willebrand factor Arg578\u2192Gln\u2014a type-IIB von Willebrand disease mutation affects binding to glycoprotein-Ib but not to collagen or heparin","volume":"267","author":"Randi","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<57::AID-AJH11>3.0.CO;2-Z","article-title":"Search for mutations in a segment of the exon 28 of the human von Willebrand factor gene: new mutations, R1315C and R1341W, associated with type 2M and 2B variants","volume":"59","author":"Casana","year":"1998","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0137_RF48","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V83.6.1542.1542","article-title":"Leu\u2192Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease","volume":"83","author":"Hilbert","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF49","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2141.1995.tb05423.x","article-title":"Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factor","volume":"91","author":"Hilbert","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1657568","article-title":"Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene","volume":"78","author":"Meyer","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF53","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0038-1653829","article-title":"Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor","volume":"73","author":"Gaucher","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF54","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.89.20.9846","article-title":"von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib","volume":"89","author":"Rabinowitz","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0137_RF55","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin\u2014but not botrocetin-mediated binding of von Willebrand factor to platelet","volume":"91","author":"Hillery","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF56","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.V88.7.2559.bloodjournal8872559","article-title":"Type 2M Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509\u2013Cys695 loop of von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets","volume":"88","author":"Mancuso","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF57","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0037-1613995","article-title":"Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor","volume":"84","author":"Hilbert","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF58","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1182\/blood.V95.12.3796","article-title":"Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation","volume":"95","author":"Ajzenberg","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF59","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V97.4.952","article-title":"The Arg552Cys (R1315C) mutation within the A1 loop of von Willebrand factor (vWF) induces an abnormal folding with a loss-of-function resulting in 2A-like phenotype of von Willebrand disease. Study of ten patients and of mutated recombinant vWF","volume":"97","author":"Ribba","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF60","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood.V86.3.1010.1010","article-title":"Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF","volume":"86","author":"Hilbert","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF61","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type-IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.1993.tb04637.x","article-title":"Substitution of cysteine for phenylalanine-751 in mature von Willebrand factor is a novel candidate mutation in a family with type-IIA von Willebrand disease","volume":"83","author":"Gaucher","year":"1993","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF63","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0037-1614208","article-title":"A new (K1518E) candidate mutation detected by universal heteroduplex generator analysis in a patient with type 2A (phenotype IIA) von Willebrand disease","volume":"79","author":"Enayat","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF64","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V83.6.1551.1551","article-title":"Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations","volume":"83","author":"Lyons","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF65","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/s-0038-1648510","article-title":"3 distinct candidate point mutations of the von Willebrand factor gene in 4 patients with type-IIA von Willebrand disease","volume":"67","author":"Sugiura","year":"1992","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0609.1993.tb00602.x","article-title":"Two new candidate mutations in type IIA von Willebrand's disease (Arg834Gly, Gly846Arg) and one polymorphism (Tyr821Cys) in the A2 region of the von Willebrand factor","volume":"51","author":"Donner","year":"1993","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF67","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V82.3.830.830","article-title":"Identification of 3 candidate mutations causing type-IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method","volume":"82","author":"Inbal","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF68","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0038-1648511","article-title":"Characterization of 3 mutations causing von Willebrand disease type-IIA in 5 unrelated families","volume":"67","author":"Inbal","year":"1992","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF69","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1365-2141.1998.01064.x","article-title":"Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28","volume":"103","author":"Bernardi","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF70","first-page":"757","article-title":"Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type-IIA vWD mutation (Ile865 to Thr)","volume":"48","author":"Iannuzzi","year":"1991","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.2001.0137_RF71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1096-8652(199904)60:4<309::AID-AJH10>3.0.CO;2-P","article-title":"Identification of a new candidate mutation, G1629R, in a family with type 2A von Willebrand disease","volume":"60","author":"Casana","year":"1999","journal-title":"American Journal of Haematology"},{"key":"10.1053\/beha.2001.0137_RF72","doi-asserted-by":"crossref","first-page":"23209","DOI":"10.1016\/S0021-9258(18)50078-8","article-title":"Characterization of recombinant von Willebrand factor corresponding to mutations in type-IIA and type-IIB von Willebrand disease","volume":"267","author":"Ribba","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF73","first-page":"415","article-title":"Molecular study of von Willebrand disease\u2014identification of potential mutations in patients with type-IIA and type-IIB","volume":"3","author":"Pietu","year":"1992","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.2001.0137_RF74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0037-1614030","article-title":"A new candidate missense mutation (Leu1657Ile) in an apparent asymptomatic type 2A (phenotype IIA) von Willebrand disease family","volume":"84","author":"Enayat","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0038-1650564","article-title":"A novel mutation Gly1672\u2192Arg in type 2A and a homozygous mutation in type 2B von Willebrand disease","volume":"76","author":"Hagiwara","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0137_RF76","first-page":"411","article-title":"Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII\/von Willebrand factor in subtypes of classic (type 1) and variant (type IIA) von Willebrand's disease","volume":"101","author":"Weiss","year":"1983","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1053\/beha.2001.0137_RF77","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI115376","article-title":"Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit","volume":"88","author":"Dent","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0137_RF78","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF79","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiological cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF80","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/blood.V87.7.2788.bloodjournal8772788","article-title":"Analysis of Arg834Gln and Val902Glu type 2A von Willebrand disease mutations. Studies with recombinant von Willebrand factor and correlation with patient characteristics","volume":"87","author":"Englender","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF81","unstructured":"Ribba, A, S, Loisel, I, Lavergne, J, M, Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) leads to a new variant of von Willebrand disease with defective binding of VWF to collagen"},{"key":"10.1053\/beha.2001.0137_RF82","doi-asserted-by":"crossref","first-page":"25585","DOI":"10.1074\/jbc.M002654200","article-title":"Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor","volume":"275","author":"Katsumi","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0137_RF83","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V63.6.1369.1369","article-title":"A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID)","volume":"63","author":"Kinoshita","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0137_RF84","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys to Arg mutation in type IID von Willebrand disease","volume":"93","author":"Schneppenheim","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0137_RF85","first-page":"34","article-title":"Molecular genetics of von Willebrand disease","volume":"41","author":"Mazurier","year":"1998","journal-title":"Annales de Genetique"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:26:25Z","timestamp":1621146385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901379"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0137","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}